Ang II and Ang III modulate PTZ seizure threshold in non-stressed and stressed mice: Possible involvement of noradrenergic mechanism

Neuropeptides

Volumn 40, Issue 5, 2006, Pages 339-348

  Tchekalarova, Jana ^a   Georgiev, Vasil ^a  

^a INSTITUTE OF PHYSIOLOGY   (Bulgaria)

Author keywords

Ang II; Ang III, Losartan; Noradrenergic system, mice; PD 123319; PTZ seizure threshold; Restraint stress

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ALPHA 1 ADRENERGIC RECEPTOR; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN III; ANTICONVULSIVE AGENT; DESIPRAMINE; LOSARTAN; PENTETRAZOLE; PEPTIDE; PRAZOSIN; SODIUM CHLORIDE; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLONUS; CONTROLLED STUDY; CONVULSION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; GENERALIZED CLONUS; HINDLIMB; IMMOBILIZATION STRESS; MALE; MOUSE; MYOCLONUS; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; SEIZURE; SEIZURE THRESHOLD; STRESS; TONIC HINDLIMB EXTENSION;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC UPTAKE INHIBITORS; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN III; ANIMALS; CONVULSANTS; DESIPRAMINE; IMIDAZOLES; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; LOSARTAN; MALE; MICE; MICE, INBRED ICR; NOREPINEPHRINE; PENTYLENETETRAZOLE; PYRIDINES; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, ALPHA-2; RESTRAINT, PHYSICAL; SEIZURES; STRESS, PSYCHOLOGICAL; SYMPATHETIC NERVOUS SYSTEM;

ANIMALIA;

EID: 33751014306     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2006.07.005     Document Type: Article

References (43)

1. Aguilera G., Kiss A., Luo X., and Akbasak B.S. The renin angiotensin system and the stress response. Ann. NY Acad. Sci. 771 (1995) 173-186
2. Bagi E.E., Fekete E., Banyai D., and Lenard L. Effects of angiotensin II and AIII microinjections into the zona incerta after intra- and extracellular fluid loss. Brain Res. 1002 (2004) 110-119
3. Blume A., Undeutsch C., Zhao Y., Kaschina E., Culman J., and Unger T. ANG III induces expression of inducible transcription factors of AP-1 and Krox families in rat brain. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289 (2005) R845-R850
4. Castren E., and Saavedra J.M. Repeated stress increases the density of angiotensin II binding sites in rat paraventricular nucleus and subfornical organ. Endocrinology 122 (1988) 370-372
5. De Lima T.C., and Rae G.A. Effects of cold-restraint and swim stress on convulsions induced by pentylenetetrazol and electroshock: influence of naloxone pretreatment. Pharmacol. Biochem. Behav. 40 (1991) 297-300
6. Denny J.B., Polan-Curtain J., Wayner M.J., and Armstrong D.L. Angiotensin II blocks hippocampal long-term potentiation. Brain Res. 45 (1991) 455-464
7. Dumont E.C., Rafrafi S., Laforest S., and Drolet G. Involvement of central angiotensin receptors in stress adaptation. Neuroscience 93 (1999) 877-884
8. Eells J.B., Clough R.W., Browning R.A., and Jobe P.C. Comparative fos immunoreactivity in the brain after forebrain, brainstem, or combined seizures induced by electroshock, pentylenetetrazol, focally induced and audiogenic seizures in rats. Neuroscience 123 (2004) 279-292
9. Gelband C.H., Sumners C., Lu D., and Raizada M.K. Angiotensin receptors and norepinephrine neuromodulation: implications of functional coupling. Regul. Pept. 72 (1997) 139-145
10. Georgiev V., Tanaka M., Tsuda A., Koga C., Takeda S., Yokoo H., and Yoshida M. Effects of angiotensin II on regional brain noradrenaline metabolism in non-stressed and stressed rats. Kurume Med. J. 39 (1992) 235-244
11. Giorgi F.S., Pizzanelli C., Biagioni F., Murri L., and Fornai F. The role of norepinephrine in epilepsy: from the bench to the bedside. Neurosci. Biobehav. Rev. 28 (2004) 507-524
12. Hashimoto Y., Suemaru K., Yamamoto T., Kawakami K., Araki H., and Gomita Y. Effect of immobilization stress on anticonvulsant actions and pharmacokinetics of zonisamide in mice. Pharmacol. Biochem. Behav. 68 (2001) 7-12
13. Homayoun H., and Dehpour A.R. Differential contribution of cholecystokinin receptors to stress-induced modulation of seizure and nociception thresholds in mice. Pharmacol. Biochem. Behav. 78 (2004) 209-215
14. Ida Y., Tanaka M., Tsuda A., Tsujimaru S., and Nagasaki N. Attenuating effect of diazepam on stress-induced increases in noradrenaline turnover in specific brain regions of rats: antagonism by Ro 15-1788. Life Sci. 37 (1985) 2491-2498
15. Jezova D., Ochedalski T., Kiss A., and Aguilera G. Brain angiotensin II modulates sympathoadrenal and hypothalamic pituitary adrenocortical activation during stress. J. Neuroendocrinol. 10 (1998) 67-72
16. Keller-Wood M., Kimura B., Shinsako J., and Phillips M.I. Interaction between CRF and angiotensin II in control of ACTH and adrenal steroids. Am. J. Physiol. 250 (1986) R396-R402
17. Kiss A., Jurkovicova D., Jezova D., and Krizanova O. Changes in angiotensin AT1 receptor mRNA levels in the rat brain after immobilization stress and inhibition of central nitric oxide synthase. Endocr. Regul. 35 (2001) 65-70
18. Kleinrok Z., Gustaw J., and Czuczwar S.J. Influence of antidepressant drugs on seizure susceptibility and the anticonvulsant activity of valproate in mice. J Neural. Transm. Suppl. 34 (1991) 85-90
19. Kregel K.C., Stauss H., and Unger T. Modulation of autonomic nervous system adjustments to heat stress by central ANG II receptor antagonism. Am. J. Physiol. 266 (1994) R1985-R1991
20. Leong D., Terron J., Falcon-Neri A., Armando I., Ito T., Johren O., Tonelli L.H., Hoe K.-L., and Saavedra J. Restraint stress modulates brain, pituitary and adrenal expression of angiotensin II AT1A, AT1B, and AT2 receptors. Neuroendocrinology 75 (2002) 227-240
21. Livett B.G., Marley P.D., Wan D.C., and Zhou X.F. Peptide regulation of adrenal medullary function. J. Neural. Transm. Suppl. 29 (1990) 77-89
22. Lösher W., and Fiedler M. The role of technical biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. Seasonal influences on maximal electroshock and pentylenetetrazol seizure thresholds. Epilepsy Res. 25 (1996) 3-10
23. Ma S., and Morilak D.A. Chronic intermittent cold stress sensitises the hypothalamic-pituitary-adrenal response to a novel acute stress by enhancing noradrenergic influence in the rat paraventricular nucleus. J. Neuroendocrinol. 17 (2005) 761-769
24. Nutt D.J., Taylor S.C., and Little H.J. Optimizing the pentetrazol infusion test for seizure threshold measurement. J. Pharm. Pharmacol. 38 (1986) 697-698
25. Pendleton R.G., Gessner G., Horner E., and Rhone-Poulenc R. Comparative effects of angiotensin II and angiotensin III in rabbit adrenal and aortic tissues. J. Pharmacol. Exp. Ther. 256 (1991) 614-620
26. Pericic D., Svob D., Jazvinscak M., and Mirkovic K. Anticonvulsive effect of swim stress in mice. Pharmacol. Biochem. Behav. 66 (2000) 879-886
27. Raghavendra V., Chopra K., and Kulkarni S.K. Brain renin angiotensin system (RAS) in stress-induced analgesia and impaired retention. Peptides 20 (1999) 335-342
28. Saavedra J.M., Ando H., Armando I., Baiardi G., Bregonzio C., Jezova M., and Zhou J. Brain angiotensin II, an important stress hormone: regulatory sites and therapeutic opportunities. Ann. NY Acad. Sci. 1018 (2004) 76-84
29. Saavedra J.M., Ando A., Armando I., Baiardi G., Bregonzio C., Juorio A., and Macova M. Antistress and antianxiety effects of centrally acting angiotensin II At1 receptor antagonists. Regul. Pept. 128 (2005) 227-238
30. Saiki Y., Watanabe T., Tan N., Matsuzaki M., and Nakamura S. Role of central ANG II receptors in stress-induced cardiovascular and hyperthermic responses in rats. Am. J. Physiol. 272 (1997) R26-R33
31. Soubrie P., Thiebot M.H., Jobert A., Montastruc J.L., Hery F., and Hamon M. Decreased convulsant potency of picrotoxin and pentetrazol and enhanced [3H]flunitrazepam cortical binding following stressful manipulations in rats. Brain Res. 189 (1980) 505-517
32. Szot P., Lester M., Laughlin M.L., Palmiter R.D., Liles L.C., and Weinshenker D. The anticonvulsant and proconvulsant effects of alpha2-adrenoreceptor agonists are mediated by distinct populations of alpha2A-adrenoreceptors. Neuroscience 126 (2004) 795-803
33. Tanaka M., Kohno Y., Tsuda A., Nakagawa R., Ida Y., Iimori K., Hoaki Y., and Nagasaki N. Differential effects of morphine on noradrenaline release in brain regions of stressed and non-stressed rats. Brain Res. 275 (1983) 105-115
34. Tchekalarova J., and Georgiev V. Angiotensin peptides modulatory system: how is it implicated in the control of seizure susceptibility?. Life Sci. 76 (2005) 955-970
35. Tchekalarova J., and Georgiev V. Effect of acute versus chronic theophylline administration on acute restraint stress-induced increase of pentylenetetrazol seizure threshold in mice. Brain Res. Bull. 68 (2006) 464-468
36. 1 receptors. Brain Res. Bull. 56 (2001) 87-91
37. Trachte G.J., and Peach M.J. A potent noncompetitive angiotensin II antagonist induces only competitive inhibition of angiotensin III responses. J. Cardiovasc. Pharmacol. 5 (1983) 1025-1033
38. U{combining double acute accent}resin Y., Erbaş B., O{combining double acute accent}zek M., Ozko{combining double acute accent}k E., and Gu{combining double acute accent}rol A.O. Lozartan may prevent the elevation of plasma glucose, corticosterone and catecholamine levels induced by chronic stress. J. Renin-Angiotensin-Aldosterone Syst. 5 (2004) 93-96
39. Weinshenker D., Szot P., Miller N.S., and Palmiter R.D. Alpha(1) and beta(2) adrenoreceptor agonists inhibit pentylenetetrazole-induced seizures in mice lacking norepinephrine. J. Pharmacol. Exp. Ther. 298 (2001) 1042-1048
40. Wright J.W., and Harding J.W. Brain angiotensin receptor subtypes in the control of physiological and behavioral responses. Neurosci. Biobehav. Rev. 18 (1994) 21-53
41. Wu H.Q., Tullii M., Samanin R., and Vezzani A. Norepinephrine modulates seizures induced by quinolinic acid in rats: selective and distinct roles of alpha-adrenoceptor subtypes. Eur. J. Pharmacol. 138 (1987) 309-318
42. Yang G., Wan Y., and Zhu Y. Angiotensin II-an important stress hormone. Biol. Signals 5 (1996) 1-8
43. Zini S., Fournie-Zaluski M.C., Chauvel E., Roques B.P., Corvol P., and Llorens-Cortes C. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc. Natl. Acad. Sci. USA 93 (1996) 11968-11973